C07C 235/60
Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms
Official title: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07C235/60 (Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms) appears on 319 US grants and 306 published applications in this corpus.
Search patents in C07C- Granted patents
- 319
- Published applications
- 306
- Assignees
- 201
- Inventors
- 1,016
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 8 | 0 |
| 1998 | 13 | 0 |
| 1999 | 17 | 0 |
| 2000 | 8 | 0 |
| 2001 | 15 | 4 |
| 2002 | 12 | 9 |
| 2003 | 12 | 13 |
| 2004 | 6 | 17 |
| 2005 | 8 | 31 |
| 2006 | 10 | 15 |
| 2007 | 16 | 15 |
| 2008 | 19 | 15 |
| 2009 | 12 | 19 |
| 2010 | 11 | 15 |
| 2011 | 6 | 11 |
| 2012 | 14 | 12 |
| 2013 | 10 | 11 |
| 2014 | 12 | 15 |
| 2015 | 6 | 17 |
| 2016 | 13 | 13 |
| 2017 | 11 | 14 |
| 2018 | 8 | 3 |
| 2019 | 7 | 7 |
| 2020 | 4 | 8 |
| 2021 | 9 | 14 |
| 2022 | 7 | 8 |
| 2023 | 5 | 10 |
| 2024 | 3 | 4 |
| 2025 | 6 | 5 |
| 2026 | 4 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adamantanyl-substituted benzamide compounds and their use as P2X7 receptor antagonists30 Jun 2026US 12,668,568 B2The University of Sydney
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium9 Jun 2026US 12,649,824 B2Resonac Corporation
- Bioactive phenolate ionic complexes21 Apr 2026US 12,606,536 B2Hadasit Medical Research Services and Development Ltd.
- Sphingolipid containing salicylic acid derivative and composition comprising same7 Apr 2026US 12,594,230 B2Croda Korea Ltd
- Hydroxybenzamide derivatives and methods of use in treating diabetes30 Dec 2025US 12,509,429 B2The Board of Regents of the University of Oklahoma
- Polycyclic thyroid hormone b receptor agonist and use thereof19 Feb 2026US 2026/0048060 A1Cascade Pharmaceuticals, Inc.
- N-[8-(2-hydroxybenzoyl)amino]potassium octanoate crystal polymorph, and preparation method therefor and use thereof27 Nov 2025US 2025/0361201 A1Sciwind Biosciences Co., Ltd.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium13 Nov 2025US 2025/0349317 A1Resonac Corporation
- Novel cannabinoid derivatives24 Jul 2025US 2025/0236578 A1Cannasoul Analytics Ltd.
- Lipid conjugates for the delivery of therapeutic agents to cns tissue10 Jul 2025US 2025/0223597 A1Arrowhead Pharmaceuticals, Inc.
Most cited
By later US patents
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Compounds and compositions for delivering active agents125US 5,866,536 AEmisphere Technologies, Inc. · 1999
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Aryl and heteroaryl compounds, compositions and methods of use99US 7,501,538 B2TransTech Pharma, Inc. · 2009
- Aryl and heteroaryl compounds, compositions, and methods of use94US 7,459,472 B2TransTech Pharma, Inc. · 2008